A multicentre, dose finding, phase II Study of CP-4055 in combination with Sorafenib in patients with metastatic malignant melanoma

Update Il y a 4 ans
Reference: EUCTR2007-000915-28

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the objective tumour response in patients with metastatic malignt melanoma when treated with CP-4055 for infusion D1-5/4w in combination with sorafenib


Inclusion criteria

  • A multicentre, dose finding, phase II Study of CP-4055 in combination with Sorafenib in patients with metastatic malignant melanoma

Links